2015 ASCO AM Public Tuesday - ASCO


Powered by SmugMug Log In
Myeloma Oral Abstract session

Myeloma Oral Abstract session

Chicago, IL - 2015 ASCO Annual Meeting - Meletios A. Dimopoulos, MD presents Carfilzomib and dexamethasone (Kd) vs bortezomib and dexamethasone (Vd) in patients (pts) with relapsed multiple myeloma (RMM): Results from the phase III study ENDEAVOR during Myeloma Oral Abstract session at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Tuesday, June 2, 2015. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the 51st Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Todd Buchanan 2015 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org